A clinical trial to compare tiragolumab plus atezolizumab versus placebo plus atezolizumab in people with non-small cell lung cancer
A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy
-
Cancer -
Lung Cancer -
Non-Small Cell Lung Cancer (NSCLC)
For the latest version of this information please go to www.forpatients.roche.com